251 related articles for article (PubMed ID: 25003724)
21. HLA and Delayed Drug-Induced Hypersensitivity.
Sousa-Pinto B; Correia C; Gomes L; Gil-Mata S; Araújo L; Correia O; Delgado L
Int Arch Allergy Immunol; 2016; 170(3):163-79. PubMed ID: 27576480
[TBL] [Abstract][Full Text] [Related]
22. Human Leukocyte Antigen Associations in Drug Hypersensitivity Reactions.
Schutte RJ; Sun Y; Li D; Zhang F; Ostrov DA
Clin Lab Med; 2018 Dec; 38(4):669-677. PubMed ID: 30420060
[TBL] [Abstract][Full Text] [Related]
23. Pharmacogenomics of adverse drug reactions: implementing personalized medicine.
Wei CY; Lee MT; Chen YT
Hum Mol Genet; 2012 Oct; 21(R1):R58-65. PubMed ID: 22907657
[TBL] [Abstract][Full Text] [Related]
24. Genetic factors in the predisposition to drug-induced hypersensitivity reactions.
Pirmohamed M
AAPS J; 2006 Feb; 8(1):E20-6. PubMed ID: 16584129
[TBL] [Abstract][Full Text] [Related]
25. Tailoring of recommendations to reduce serious cutaneous adverse drug reactions: a pharmacogenomics approach.
Tan-Koi WC; Sung C; Chong YY; Lateef A; Pang SM; Vasudevan A; Aw D; Lui NL; Lee SX; Ren EC; Koay ES; Tay YK; Lim YL; Lee HY; Dong D; Loke C; Tan L; Limenta M; Lee EJ; Toh D; Chan CL
Pharmacogenomics; 2017 Jun; 18(9):881-890. PubMed ID: 28594314
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of cytokine profile and HLA association in benznidazole related cutaneous reactions in patients with Chagas disease.
Salvador F; Sánchez-Montalvá A; Martínez-Gallo M; Sala-Cunill A; Viñas L; García-Prat M; Aparicio G; Sao Avilés A; Artaza MÁ; Ferrer B; Molina I
Clin Infect Dis; 2015 Dec; 61(11):1688-94. PubMed ID: 26265500
[TBL] [Abstract][Full Text] [Related]
27. Human leukocyte antigen (HLA) pharmacogenomic tests: potential and pitfalls.
Daly AK
Curr Drug Metab; 2014 Feb; 15(2):196-201. PubMed ID: 24694233
[TBL] [Abstract][Full Text] [Related]
28. Presence of the HLA-A*3101 allele in a familial case of drug reaction with eosinophilia and systemic symptoms, secondary to carbamazepine.
Anjum N; Polak ME; Ardern-Jones M; Cooper HL
Clin Exp Dermatol; 2014 Apr; 39(3):307-9. PubMed ID: 24635066
[TBL] [Abstract][Full Text] [Related]
29. Human leukocyte antigen genetic risk factors of drug-induced liver toxicology.
Grove JI; Aithal GP
Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):395-409. PubMed ID: 25491399
[TBL] [Abstract][Full Text] [Related]
30. Severe Cutaneous Adverse Reactions: The Pharmacogenomics from Research to Clinical Implementation.
Su SC; Hung SI; Fan WL; Dao RL; Chung WH
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27854302
[TBL] [Abstract][Full Text] [Related]
31. Human Leukocyte Antigen (HLA) Testing in Pharmacogenomics.
Moyer AM; Gandhi MJ
Methods Mol Biol; 2022; 2547():21-45. PubMed ID: 36068459
[TBL] [Abstract][Full Text] [Related]
32. [Cutaneous drug reactions: pharmacogenetic news].
Buffard V; Roujeau JC
Arch Pediatr; 2004 May; 11(5):489-92. PubMed ID: 15135444
[TBL] [Abstract][Full Text] [Related]
33. HLA alleles and drug hypersensitivity reactions.
Profaizer T; Eckels D
Int J Immunogenet; 2012 Apr; 39(2):99-105. PubMed ID: 22136512
[TBL] [Abstract][Full Text] [Related]
34. An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity.
Chen CB; Abe R; Pan RY; Wang CW; Hung SI; Tsai YG; Chung WH
J Immunol Res; 2018; 2018():6431694. PubMed ID: 29651444
[TBL] [Abstract][Full Text] [Related]
35. HLA and drug-induced toxicity.
Phillips EJ; Mallal SA
Curr Opin Mol Ther; 2009 Jun; 11(3):231-42. PubMed ID: 19479656
[TBL] [Abstract][Full Text] [Related]
36. [Pharmacogenetics].
Merk HF
Hautarzt; 2010 Aug; 61(8):650-3. PubMed ID: 20644905
[TBL] [Abstract][Full Text] [Related]
37. Recent advances in the genetics and immunology of Stevens-Johnson syndrome and toxic epidermal necrosis.
Chung WH; Hung SI
J Dermatol Sci; 2012 Jun; 66(3):190-6. PubMed ID: 22541332
[TBL] [Abstract][Full Text] [Related]
38. Drug hypersensitivity reactions involving skin.
Hausmann O; Schnyder B; Pichler WJ
Handb Exp Pharmacol; 2010; (196):29-55. PubMed ID: 20020258
[TBL] [Abstract][Full Text] [Related]
39. The role of HLA genes in pharmacogenomics: unravelling HLA associated adverse drug reactions.
Illing PT; Purcell AW; McCluskey J
Immunogenetics; 2017 Aug; 69(8-9):617-630. PubMed ID: 28695285
[TBL] [Abstract][Full Text] [Related]
40. Pharmacogenomics and adverse drug reactions: Primetime and not ready for primetime tests.
Khan DA
J Allergy Clin Immunol; 2016 Oct; 138(4):943-955. PubMed ID: 27720019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
